$MXCT·8-K

MAXCYTE, INC. · Jun 17, 4:59 PM ET

Compare

MAXCYTE, INC. 8-K

Research Summary

AI-generated summary

Updated

MaxCyte, Inc. Reports Annual Meeting Results; Directors Elected, Auditor Ratified

What Happened
MaxCyte, Inc. (MXCT) filed an 8-K on June 17, 2026 reporting the results of its Annual Meeting held that day. Stockholders elected three Class II directors—Patrick Balthrop, Cynthia Collins and Stanley Erck—and ratified the Audit Committee’s selection of CohnReznick LLP as the company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. The proxy statement referenced was filed April 29, 2026.

Key Details

  • Director election vote totals:
    • Patrick Balthrop: For 39,760,379; Withhold 12,728,826; Broker Non‑Votes 17,814,976.
    • Cynthia Collins: For 46,886,614; Withhold 5,602,591; Broker Non‑Votes 17,814,976.
    • Stanley Erck: For 40,908,701; Withhold 11,580,504; Broker Non‑Votes 17,814,976.
  • Auditor ratification: CohnReznick LLP was ratified with Votes For 70,227,193; Votes Against 46,732; Abstentions 30,256.
  • The 8-K was signed by CFO Parmeet Ahuja and filed June 17, 2026.

Why It Matters
The voting results confirm the board composition for Class II seats and formalize the independent auditor for fiscal 2026—both important governance outcomes that affect oversight of MaxCyte’s financial reporting and strategic direction. Large broker non‑vote totals indicate a portion of shares were not voted by brokers, which can affect vote dynamics but did not prevent the nominees or auditor from being approved.

Loading document...